---
title: Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen
  Antiviral Potential and Safety
date: '2024-08-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39136957/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240813182518&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: In the aftermath of the COVID-19 pandemic, opportunities to modulate
  biological pathways common to the lifecycles of viruses need to be carefully considered.
  N-linked glycosylation in humans is mediated exclusively by the oligosaccharyltransferase
  complex and is frequently hijacked by viruses to facilitate infection. As such,
  STT3A/B, the catalytic domain of the OST complex, became an intriguing drug target
  with broad-spectrum antiviral potential. However, due to the critical role ...
disable_comments: true
---
In the aftermath of the COVID-19 pandemic, opportunities to modulate biological pathways common to the lifecycles of viruses need to be carefully considered. N-linked glycosylation in humans is mediated exclusively by the oligosaccharyltransferase complex and is frequently hijacked by viruses to facilitate infection. As such, STT3A/B, the catalytic domain of the OST complex, became an intriguing drug target with broad-spectrum antiviral potential. However, due to the critical role ...